Improving cervical cancer screening and treatment in Mozambique
A hybrid type III effectiveness-implementation, pragmatic intervention trial for cervical cancer screen and treat in Mozambique
['FUNDING_U01'] · TULANE UNIVERSITY OF LOUISIANA · NIH-11000924
This study is looking to make cervical cancer screening easier and more comfortable for women in Mozambique by letting them collect their own samples for HPV testing, so they can get the care they need more easily.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TULANE UNIVERSITY OF LOUISIANA (nih funded) |
| Locations | 1 site (NEW ORLEANS, UNITED STATES) |
| Trial ID | NIH-11000924 on ClinicalTrials.gov |
What this research studies
This research aims to enhance cervical cancer screening and treatment in Mozambique by implementing a hybrid approach that combines effectiveness and implementation strategies. It focuses on using self-sampling for HPV testing, which allows women to collect samples themselves, thereby increasing accessibility and comfort. The study will evaluate the best practices for deploying this Screen & Treat approach, guided by a framework that promotes the integration of evidence-based practices into clinical care. By addressing barriers to screening, the research seeks to improve health outcomes for women at risk of cervical cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are women aged 25-49 living in Mozambique who are at risk for cervical cancer.
Not a fit: Patients outside the target age range or those not residing in Mozambique may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce cervical cancer deaths by improving access to effective screening and treatment options for women in Mozambique.
How similar studies have performed: Preliminary studies in Mozambique have shown that HPV DNA testing and self-collection methods are feasible and preferred by participants, indicating potential for success in this approach.
Where this research is happening
NEW ORLEANS, UNITED STATES
- TULANE UNIVERSITY OF LOUISIANA — NEW ORLEANS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MOON, D. TROY — TULANE UNIVERSITY OF LOUISIANA
- Study coordinator: MOON, D. TROY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus, Cancer Control